Business and Economy
GSK Acquires US Cancer Biotech Nuvalent for $10.6 Billion
GSK announces its largest-ever acquisition, buying US cancer biotech Nuvalent for $10.6 billion in a major oncology push under new CEO Luke Miels.
—4 min read
Tag
#Gsk
3 articles
HealthScience
Breakthrough Drug Offers Functional Cure for Hepatitis B
Phase III trials show bepirovirsen achieves functional cure in 19% of chronic hepatitis B patients, marking a major treatment advance.
—5 min read
EconomyLabor
GSK Workers in Belgium Denounce 'Unacceptable' Cuts
Renewed labor tensions at GSK in Belgium as workers denounce reduced severance terms for six employees, calling the situation 'extremely worrying.'
—4 min read